ArticleFrontiers in immunology2025

Combination therapy with toripalimab and lenvatinib in metastatic type 2 papillary renal cell carcinoma: a Case Report.

Wende Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.